Literature DB >> 19034481

Physiology of vitreous surgery.

Einar Stefánsson1.   

Abstract

Vitreous surgery has various physiological and clinical consequences, both beneficial and harmful. Vitrectomy reduces the risk of retinal neovascularization, while increasing the risk of iris neovascularization, reduces macular edema and stimulates cataract formation. These clinical consequences may be understood with the help of classical laws of physics and physiology. The laws of Fick, Stokes-Einstein and Hagen-Poiseuille state that molecular transport by diffusion or convection is inversely related to the viscosity of the medium. When the vitreous gel is replaced with less viscous saline, the transport of all molecules, including oxygen and cytokines, is facilitated. Oxygen transport to ischemic retinal areas is improved, as is clearance of VEGF and other cytokines from these areas, thus reducing edema and neovascularization. At the same time, oxygen is transported faster down a concentration gradient from the anterior to the posterior segment, while VEGF moves in the opposite direction, making the anterior segment less oxygenated and with more VEGF, stimulating iris neovascularization. Silicone oil is the exception that proves the rule: it is more viscous than vitreous humour, re-establishes the transport barrier to oxygen and VEGF, and reduces the risk for iris neovascularization in the vitrectomized-lentectomized eye. Modern vitreous surgery involves a variety of treatment options in addition to vitrectomy itself, such as photocoagulation, anti-VEGF drugs, intravitreal steroids and release of vitreoretinal traction. A full understanding of these treatment modalities allows sensible combination of treatment options. Retinal photocoagulation has repeatedly been shown to improve retinal oxygenation, as does vitrectomy. Oxygen naturally reduces VEGF production and improves retinal hemodynamics. The VEGF-lowering effect of photocoagulation and vitrectomy can be augmented with anti-VEGF drugs and the permeability effect of VEGF reduced with corticosteroids. Starling's law explains vasogenic edema, which is controlled by osmotic and hydrostatic gradients between vessel and tissue. It explains the effect of VEGF-induced vascular permeability changes on plasma protein leakage and the osmotic gradient between vessel and tissue. At the same time, it takes into account hemodynamic changes that affect the hydrostatic gradient. This includes the influence of arterial blood pressure, and the effect oxygen (laser treatment) has in constricting retinal arterioles, increasing their resistance, and thus reducing the hydrostatic pressure in the microcirculation. Reduced capillary hydrostatic pressure and increased osmotic gradient reduce water fluxes from vessel to tissue and reduce edema. Finally, Newton's third law explains that vitreoretinal traction decreases hydrostatic tissue pressure in the retina, increases the pressure gradient between vessel and tissue, and stimulates water fluxes from vessel into tissue, leading to edema.

Entities:  

Mesh:

Year:  2008        PMID: 19034481     DOI: 10.1007/s00417-008-0980-7

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  155 in total

Review 1.  Use of temporal information to quantify vascular leakage in fluorescein angiography of the retina.

Authors:  R P Phillips; P G Ross; P F Sharp; J V Forrester
Journal:  Clin Phys Physiol Meas       Date:  1990

2.  Laser-induced changes in intraretinal oxygen distribution in pigmented rabbits.

Authors:  Dao-Yi Yu; Stephen J Cringle; Erning Su; Paula K Yu; Mark S Humayun; Giorgio Dorin
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-03       Impact factor: 4.799

3.  Oxygen distribution in the rabbit eye and oxygen consumption by the lens.

Authors:  Ying-Bo Shui; Jia-Jan Fu; Claudia Garcia; Lisa K Dattilo; Ramya Rajagopal; Sam McMillan; Garbo Mak; Nancy M Holekamp; Angie Lewis; David C Beebe
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-04       Impact factor: 4.799

4.  The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology.

Authors:  E Stefánsson
Journal:  Acta Ophthalmol Scand       Date:  2001-10

5.  Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathy.

Authors:  Søren T Knudsen; Toke Bek; Per L Poulsen; Marianne N Hove; Michael Rehling; Carl E Mogensen
Journal:  Diabetes Care       Date:  2002-12       Impact factor: 19.112

6.  Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown.

Authors:  Jeffrey L Edelman; David Lutz; Marisol R Castro
Journal:  Exp Eye Res       Date:  2005-02       Impact factor: 3.467

7.  Role of the vitreous in age-related macular degeneration.

Authors:  F Ondeş; G Yilmaz; M A Acar; N Unlü; H Kocaoğlan; A K Arsan
Journal:  Jpn J Ophthalmol       Date:  2000 Jan-Feb       Impact factor: 2.447

8.  Cataract development after trabeculectomy with mitomycin C: a 1-year study.

Authors:  L Daugeliene; T Yamamoto; Y Kitazawa
Journal:  Jpn J Ophthalmol       Date:  2000 Jan-Feb       Impact factor: 2.447

Review 9.  Intravitreal steroids in the management of macular oedema.

Authors:  Sobha Sivaprasad; Peter McCluskey; Susan Lightman
Journal:  Acta Ophthalmol Scand       Date:  2006-12

10.  Transcorneal oxygenation of the preretinal vitreous.

Authors:  C A Wilson; J D Benner; B A Berkowitz; C B Chapman; R M Peshock
Journal:  Arch Ophthalmol       Date:  1994-06
View more
  71 in total

1.  Comparison of two probe designs for determining intraocular oxygen distribution.

Authors:  Young-Hoon Park; Ying-Bo Shui; David C Beebe
Journal:  Br J Ophthalmol       Date:  2010-09-23       Impact factor: 4.638

2.  Posterior vitreous detachment with microplasmin alters the retinal penetration of intravitreal bevacizumab (Avastin) in rabbit eyes.

Authors:  David T Goldenberg; Frank J Giblin; Mei Cheng; Shravan K Chintala; Michael T Trese; Kimberly A Drenser; Alan J Ruby
Journal:  Retina       Date:  2011-02       Impact factor: 4.256

Review 3.  Therapeutic Options in Refractory Diabetic Macular Oedema.

Authors:  Sanket U Shah; Raj K Maturi
Journal:  Drugs       Date:  2017-04       Impact factor: 9.546

4.  Current practice in the management of branch retinal vein occlusion in Japan: Survey results of retina specialists in Japan.

Authors:  Yuichiro Ogura; Mineo Kondo; Kazuaki Kadonosono; Masahiko Shimura; Motohiro Kamei; Akitaka Tsujikawa
Journal:  Jpn J Ophthalmol       Date:  2019-08-19       Impact factor: 2.447

5.  Is traction the cause or the effect?

Authors:  David Wong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-12       Impact factor: 3.117

6.  Efficacy of vitrectomy in improving the outcome of Bacillus cereus endophthalmitis.

Authors:  Michelle C Callegan; Scott Guess; Nanette R Wheatley; Dustin C Woods; Gabe Griffin; Brandt J Wiskur; Robert Leonard
Journal:  Retina       Date:  2011-09       Impact factor: 4.256

Review 7.  Management of diabetic macular edema in Japan: a review and expert opinion.

Authors:  Hiroko Terasaki; Yuichiro Ogura; Shigehiko Kitano; Taiji Sakamoto; Toshinori Murata; Akito Hirakata; Tatsuro Ishibashi
Journal:  Jpn J Ophthalmol       Date:  2017-12-05       Impact factor: 2.447

8.  Vision-related quality of life and visual function following intravitreal bevacizumab injection for persistent diabetic macular edema after vitrectomy.

Authors:  Yoshifumi Okamoto; Fumiki Okamoto; Takahiro Hiraoka; Tetsuro Oshika
Journal:  Jpn J Ophthalmol       Date:  2014-04-29       Impact factor: 2.447

9.  Vascular endothelial growth factor modulates the function of the retinal pigment epithelium in vivo.

Authors:  Mohammad Dahrouj; Oday Alsarraf; Jake C McMillin; Yueying Liu; Craig E Crosson; Zsolt Ablonczy
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-09       Impact factor: 4.799

10.  Efficacy of vitrectomy and inner limiting membrane peeling in age-related macular degeneration resistant to anti-vascular endothelial growth factor therapy, with vitreomacular traction or epiretinal membrane.

Authors:  Shuhei Kimura; Yuki Morizane; Shinji Toshima; Mika Hosogi; Fumiaki Kumase; Mio Hosokawa; Yusuke Shiode; Atsushi Fujiwara; Fumio Shiraga
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-03-08       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.